News
The report highlights market opportunities in dementia clinical trials by providing insights into global trial landscapes, top locations, and prominent companiesDublin, Aug. 26, 2025 (GLOBE NEWSWIRE) ...
Key market opportunities for bispecific antibody drug conjugates (BsADCs) include their potential to revolutionize cancer treatment through enhanced tumor selectivity and reduced off-target effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results